2-Fluoroadenine Synthesis with Protected Intermediates for Scale-Up
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for producing 2-fluoroadenine, a key intermediate in the synthesis of antiviral nucleoside EFdA, face challenges such as low yields, laborious work-up conditions, and unsuitable reaction conditions for scaled-up preparations, especially when producing multi-kilogram quantities.
Innovation Solution
A process involving the treatment of 2,6-dichloropurine with dihydropyran to form a protected intermediate, followed by reaction with a substituted amine and fluoride salt, then ammonia to produce 2-fluoroadenine, using high surface area potassium fluoride and mild conditions to enhance efficiency and yield.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If published routes to 2-fluoroadenine are used, then the intermediate can be produced, but the yields are low and work-up conditions are laborious
Solution Approach 1:
The patent changes the reaction parameters by using a two-step sequence: first treating 6-chloro-2-fluoropurine with ammonium fluoride to form 2-fluoroadenine, then treating with ammonia to form the amino derivative. This parameter change in reaction sequence and conditions improves yield from low published values to 74-85% and simplifies work-up by enabling direct isolation of crystalline intermediates
Solution Approach 2:
The patent introduces a protected intermediate (2-fluoro-9-(tetrahydro-2H-pyran-2-yl)-9H-purin-6-amine) as a mediator in the synthesis route. This intermediate allows for controlled reaction progression, improved yield, and simplified isolation compared to direct published methods
2Productivity
If published routes to 2-fluoroadenine are used, then the intermediate can be produced, but the reaction conditions are unsuitable for scaled up preparations
Solution Approach 1:
The patent optimizes reaction parameters for scale-up by using stable, commercially available reagents (ammonium fluoride, ammonia) and controlling reaction conditions (temperature, solvent, stoichiometry) to enable multi-kilogram production. The method achieves 74-85% yields with simple filtration and drying steps suitable for manufacturing
Solution Approach 2:
The patent segments the synthesis into distinct, controllable steps: (a) fluoride substitution to form the fluoroadenine intermediate, (b) ammonia treatment to form the amino derivative, and (c) acid treatment to release 2-fluoroadenine. This segmentation allows each step to be optimized and scaled independently
3Quantity of substance
If existing methods are used to produce multi-kilogram quantities of 2-fluoroadenine, then larger quantities of drug substance can be prepared, but the current methods provide only low yields
Solution Approach 1:
The patent changes reaction parameters including using ammonium fluoride instead of other fluoride sources, controlling the sequence of reagent addition, and optimizing solvent systems. These changes increase yield to 74-85%, enabling efficient production of multi-kilogram quantities required for advanced clinical studies
Solution Approach 2:
The patent enables continuous production by designing a reaction sequence where intermediates can be isolated and carried forward, or where steps can be performed sequentially without interruption. The high yields and simple work-up allow for continuous manufacturing processes
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This process enables the production of 2-fluoroadenine with improved yields and simplified isolation, suitable for large-scale synthesis, providing a stable intermediate for EFdA production.
Implementation Method 1
treating compound (2) with a substituted amine reagent and a fluoride salt to provide compound (3)
Implementation Method 2
treating compound (3) with an ammonia reagent to provide compound (4)
Implementation Method 3
treating compound (4) with an acid to provide 2-fluoroadenine
Data Source
AI summary
The present invention provides processes for the preparation of 2-fluoroadenine, as well as certain intermediates useful in the preparation of 2′-deoxy-4′-C-ethynyl-2-fluoroadenosine (EFdA): EFdA.